The practical consequence: if you have chronic kidney disease alongside type 2 diabetes, the choice between these drugs is not interchangeable, and it is worth naming the kidney indication explicitly when you talk to your prescriber
When Will I See Results From Semaglutide or Tirzepatide
1 Participants were assigned to take either oral semaglutide once daily or placebo
We estimated the percent mediation of the change in eGFR at week 104, potentially attributable to change in weight, by assessing how much the treatment effect on eGFR was altered by including the weight change in the regression model adjusted for baseline eGFR and baseline weight
While a single missed dose is unlikely to cause dangerous hyperglycemia in most patients, those with poorly controlled diabetes or those taking insulin or sulfonylureas should be especially vigilant
If you happen to miss a dose, consult your healthcare provider for guidance on how to proceed